Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma
Clinical trial NCT03299686 · COMPLETED
Trial details
- NCT number
- NCT03299686
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2019-04-08
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.